The Trump administration will pay $1 billion to a French company to walk away from two U.S. offshore wind leases as the administration ramps up its campaign against offshore wind and other renewable ...

A team of Johns Hopkins researchers has been awarded a five-year $15 million grant from the National Institutes of Health to develop a platform to test potential new treatments for neurological ...

AUSTIN, Texas — Texas families will have a little more time to apply for the state's "Education Freedom Account” program after a federal court order on Tuesday. The decision came hours before the ...

HOUSTON – Tuesday is the last day for Texas families to apply for the state’s new school voucher program, with the application window closing on March 17. The program, known as the Texas Education ...

A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...

Students from Allentown’s Bridgeview Academy of Health, Science, Innovation and Technology are set to benefit from a $250,000 state grant that will expand Lehigh Valley Health Network’s workforce ...

US envoys to meet Iranian officials in Geneva on Thursday Rubio warns of Iran's ballistic missile threat to US interests Vance emphasizes Iran cannot have a nuclear weapon BASSETERRE, Saint Kitts and ...

New York City has opened applications for Summer Rising 2026, a free summer learning program for kindergarten through eighth-grade students. The program, now in its sixth year, offers approximately ...

NEW YORK (AP) — The Trump family company has filed to trademark the use of the president's name on airports but says it doesn't plan on charging a fee — at least for a proposed renaming of one near ...

A gallium nitride wafer at Raytheon's foundry in Massachusetts. Raytheon is leveraging its expertise with materials like this to develop the process for manufacturing TFLN wafers under the Mastermind ...

Leading the Next Wave of Innovative IBD Therapeutics Targeting Immunometabolism: Josep Bassaganya-Riera Launches Clinical Program and Business Venture to Develop NIM-1324 for Ulcerative Colitis and ...